InnKlinikum Burghausen
- Address
- Krankenhausstrasse 1, 84489 Burghausen, Germany
InnKlinikum Burghausen - Rheumatology and Autoimmune Disease Research
InnKlinikum Burghausen is actively engaged in clinical research focused on inflammatory rheumatic diseases, with particular expertise in the management of psoriatic arthritis. The center specializes in innovative treatment strategies utilizing treat-to-target approaches and therapeutic optimization protocols for patients with autoimmune conditions.
- Psoriatic arthritis treatment optimization and disease activity monitoring
- Immunosuppressive therapy tapering strategies in chronic inflammatory conditions
- Minimal disease activity maintenance and long-term remission studies
The research center demonstrates commitment to improving quality of life for patients with psoriatic arthritis through evidence-based medication management strategies. Their clinical trials focus on determining optimal therapeutic approaches that balance disease control with minimal medication exposure, evaluating the feasibility of tapering systemic immunosuppressive therapy while maintaining minimal disease activity (MDA) status in stable patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in InnKlinikum Burghausen
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Tapering Systemic Immunosuppressive Therapy on Maintaining Minimal Disease Activity in Psoriatic Arthritis Using Methotrexate Disodium and Drug Combination | Universitaetsklinikum Erlangen AöR | Phase III | Recruiting | Sep 2020 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abatacept | 1 | Unknown | 2020-09-18 | 2020-09-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.